Carlo Giorda

5.7k total citations
117 papers, 3.1k citations indexed

About

Carlo Giorda is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Carlo Giorda has authored 117 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Endocrinology, Diabetes and Metabolism, 27 papers in Cardiology and Cardiovascular Medicine and 23 papers in Surgery. Recurrent topics in Carlo Giorda's work include Diabetes Treatment and Management (48 papers), Diabetes Management and Research (33 papers) and Metabolism, Diabetes, and Cancer (18 papers). Carlo Giorda is often cited by papers focused on Diabetes Treatment and Management (48 papers), Diabetes Management and Research (33 papers) and Metabolism, Diabetes, and Cancer (18 papers). Carlo Giorda collaborates with scholars based in Italy, Spain and United States. Carlo Giorda's co-authors include Giuseppina Russo, Salvatore De Cosmo, Antonio Nicolucci, Elisa Nada, Francesca Viazzi, Roberto Pontremoli, Pietro Guida, Antonio Ceriello, Domenico Cucinotta and Roberto Gnavi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Carlo Giorda

114 papers receiving 3.0k citations

Peers

Countries citing papers authored by Carlo Giorda

Since Specialization

Citations

This map shows the geographic impact of Carlo Giorda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlo Giorda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlo Giorda more than expected).

Fields of papers citing papers by Carlo Giorda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlo Giorda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlo Giorda. The network helps show where Carlo Giorda may publish in the future.

Co-authorship network of co-authors of Carlo Giorda

This figure shows the co-authorship network connecting the top 25 collaborators of Carlo Giorda. A scholar is included among the top collaborators of Carlo Giorda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlo Giorda. Carlo Giorda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Overcoming Therapeutic Inertia in Type 2 Diabetes: Exploring Machine Learning-Based Scenario Simulation for Improving Short-Term Glycemic Control 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Davide Masi, Fabio Baccetti, Besmir Nreu, Carlo Giorda, (unknown), (unknown), Marco Muselli, Alessandro Ozzello, (unknown), Paola Ponzani, Antonio Rossi, (unknown), (unknown), Graziano Di Cianni, Riccardo Candido	1
2	A transparent machine learning algorithm uncovers HbA1c patterns associated with therapeutic inertia in patients with type 2 diabetes and failure of metformin monotherapy 2024 ·International Journal of Medical Informatics ·Nicoletta Musacchio, (unknown), Davide Masi, Fabio Baccetti, Besmir Nreu, Carlo Giorda, (unknown), (unknown), Marco Muselli, Alessandro Ozzello, (unknown), Paola Ponzani, Antonio Rossi, (unknown), (unknown), Graziano Di Cianni, Riccardo Candido	1
3	Trends and cyclic variation in the incidence of childhood type 1 diabetes in two Italian regions over 33 years and during the COVID ‐19 pandemic 2023 ·Diabetes Obesity and Metabolism ·Rosaria Gesuita, Ivana Rabbone, (unknown), Luisa De Sanctis, Mónica Marino, (unknown), Antonio Iannilli, Davide Tinti, (unknown), Carlo Giorda, Flavia Carle, Valentino Cherubini	6
4	The legacy effect of hyperglycemia and early use of SGLT-2 inhibitors: a cohort study with newly-diagnosed people with type 2 diabetes 2023 ·The Lancet Regional Health - Europe ·Antonio Ceriello, Giuseppe Lucisano, Francesco Prattichizzo, Rosalba La Grotta, Chiara Frigé, Salvatore De Cosmo, Paolo Di Bartolo, Graziano Di Cianni, Paola Fioretto, Carlo Giorda, Roberto Pontremoli, Giuseppina Russo, Francesca Viazzi, Antonio Nicolucci	21
5	Transparent machine learning suggests a key driver in the decision to start insulin therapy in individuals with type 2 diabetes 2023 ·Journal of Diabetes ·Nicoletta Musacchio, (unknown), Paola Ponzani, (unknown), Carlo Giorda, (unknown), (unknown), Graziano Di Cianni	15
6	Linee guida europee su diabete, pre-diabete e malattie cardiovascolari: cosa c’è di nuovo? Il punto di vista del diabetologo 2020 ·Giornale italiano di cardiologia ·Carlo Giorda	1
7	Incretin-based therapy and risk of cholangiocarcinoma: a nested case–control study in a population of subjects with type 2 diabetes 2019 ·Acta Diabetologica ·Carlo Giorda, Roberta Picariello, Barbara Tartaglino, Elisa Nada, Giuseppe Costa, Roberto Gnavi	8
8	Natural history and risk factors for diabetic kidney disease in patients with T2D: lessons from the AMD-annals 2018 ·Journal of Nephrology ·Francesca Viazzi, Giuseppina Russo, Antonio Ceriello, Paola Fioretto, Carlo Giorda, Salvatore De Cosmo, Roberto Pontremoli	30
9	Five-Year Predictors of Insulin Initiation in People with Type 2 Diabetes under Real-Life Conditions 2018 ·Journal of Diabetes Research ·Sandro Gentile, Felice Strollo, Francesca Viazzi, Giuseppina Russo, Pamela Piscitelli, Antonio Ceriello, Carlo Giorda, Piero Guida, Paola Fioretto, Roberto Pontremoli, Salvatore De Cosmo, (unknown)	18
10	Predictors of chronic kidney disease in type 1 diabetes: a longitudinal study from the AMD Annals initiative 2017 ·Scientific Reports ·Pamela Piscitelli, Francesca Viazzi, Paola Fioretto, Carlo Giorda, Antonio Ceriello, Stefano Genovese, Giuseppina Russo, Pietro Guida, Roberto Pontremoli, Salvatore De Cosmo	36
11	Sexual Dysfunction in Type 2 Diabetes at Diagnosis: Progression over Time and Drug and Non-Drug Correlated Factors 2016 ·PLoS ONE ·Giovanni Corona, Carlo Giorda, Domenico Cucinotta, Piero Guida, Elisa Nada, (unknown)	27
12	Hospitalisation for heart failure and mortality associated with dipeptidyl peptidase 4 (DPP-4) inhibitor use in an unselected population of subjects with type 2 diabetes: a nested case–control study 2015 ·BMJ Open ·Carlo Giorda, Roberta Picariello, Barbara Tartaglino, Lisa Marafetti, (unknown), (unknown), Giuseppe Costa, Roberto Gnavi	24
13	Results of the Adequacy of glycemiC Control in pAtients with type 2 Diabetes mEllitus treated with Metformin monotherapY at the maximal-tolerated dose (ACCADEMY) study 2015 ·Endocrine ·(unknown), Carlo Giorda, Stefania Cercone, Elisa Nada	3
14	Trends over 8 years in quality of diabetes care: results of the AMD Annals continuous quality improvement initiative 2014 ·Acta Diabetologica ·Maria Chiara Rossi, Riccardo Candido, Antonio Ceriello, (unknown), Paolo Di Bartolo, Carlo Giorda, Katherine Esposito, Giuseppe Lucisano, Marina Maggini, Edoardo Mannucci, (unknown), Antonio Nicolucci, Fabio Pellegrini, Marco Scardapane, Giacomo Vespasiani	39
15	Comparison of direct costs of type 2 diabetes care: Different care models with different outcomes 2014 ·Nutrition Metabolism and Cardiovascular Diseases ·Carlo Giorda, Roberta Picariello, Elisa Nada, Barbara Tartaglino, Lisa Marafetti, Giuseppe Costa, Alessio Petrelli, Roberto Gnavi	11
16	Left ventricular dysfunction and outcome at two-year follow-up in patients with type 2 diabetes: The DYDA study 2013 ·Diabetes Research and Clinical Practice ·Giovanni Cioffi, Pompilio Faggiano, Donata Lucci, Aldo P. Maggioni, Valeria Manicardi, (unknown), (unknown), Serge Masson, Carlo Giorda, Mario Velussi, Andrea Di Lenarda, Paolo Verdecchia, Marco Comaschi	10
17	The implementation of international standardization of glycated hemoglobin. A "red-letter-day" for glycated hemoglobin in Italy: 1/1/11. Italian Recommendations of GLAD Working Group (A1c delegates WG). 2012 ·PubMed ·Andrea Mosca, Dario Iafusco, Franco Meschi, (unknown), Mariarosa Carta, (unknown), Carlo Giorda, (unknown), (unknown), (unknown), (unknown), (unknown), Maurizio Marra, Gerardo Medea, (unknown), F. Rossi, (unknown), (unknown), Mariella Trovati, Martina Zaninotto	2
18	The IMPROVE study--a multinational, multicentre, observational study in type 2 diabetes: results from the Italian cohort. 2010 ·PubMed ·Carlo Giorda, Massimo Boemi, Vito Borzı̀, (unknown), (unknown), (unknown)	4
19	Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective study 2009 ·Acta Diabetologica ·Giuseppina Russo, A. Di Benedetto, Domenico Magazzù, Annalisa Giandalia, Carlo Giorda, Riccardo Ientile, M. Previti, E. Di Cesare, Domenico Cucinotta	24
20	Secondary prevention of coronary artery disease in high-risk diabetic patients 2003 ·Nutrition Metabolism and Cardiovascular Diseases ·Carlo Giorda, (unknown), Stefania Spila Alegiani, Salvatore Turco, Roberto Raschetti	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact